speb/financial-data huggingface dataset:
Financial ratios for ALGOQUANT.NS — annual report dated 2023-03-31
Total revenue: 1784214.3727161998
Gross profit: -217783.19123020707
Operating income: -670816.077953715
Net income: -416406.8209500609
Capital expenditures: 99354.44579780755
Operating cash flow: -4531059.683313034
Depreciation & amortization: 27283.80024360536
Net tangible assets: 4176236.2971985387
Owner earnings: -488477.4665042631
Return on net tangible assets (%): -11.69659549273921
Buffett classification: The Gruesome
Shares outstanding: 281096028
Book value: 4176236.2971985396
Debt to equity: 0.8885492710043776
Current ratio: 1.6131134161401224
Quick ratio: 1.6131134161401224
Interest coverage ratio: -3.465299188321903
COGS to revenue (%): 112.20611124764478
SG&A to revenue (%): 4.253024221075339
Free cash flow (dilution-adjusted): -4630414.129110841
Retained earnings: 2156991.473812424
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -16.035475220628268
FCF margin (%): -259.5211763742115
Rule of 40 score: -259.5211763742115
Financial ratios for ALGOQUANT.NS — annual report dated 2024-03-31
Total revenue: 15340028.780429307
Gross profit: 2272011.0324979015
Operating income: 1513191.0300995323
Net income: 2947343.806211776
Capital expenditures: 785286.005516249
Operating cash flow: -1232461.9258903945
Depreciation & amortization: 381820.3621537355
Net tangible assets: 8230267.418155654
Owner earnings: 2543878.1628492624
Return on net tangible assets (%): 30.908815395688897
Capex to operating income (%): 51.896025676585964
Buffett classification: The Good
Shares outstanding: 281096028
Book value: 8262441.539752968
Debt to equity: 0.9422282857163591
Current ratio: 1.221951549895489
Quick ratio: 1.221951549895489
Effective tax rate (%): 20.003710478521537
Interest coverage ratio: 6.413794856155332
COGS to revenue (%): 85.18900410802021
SG&A to revenue (%): 3.634992045840972
Free cash flow (dilution-adjusted): -2017747.9314066435
Retained earnings: 8117388.176040293
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.942018380649973
FCF margin (%): -13.15348204548919
Revenue growth (%): 759.7637713833907
Rule of 40 score: 746.6102893379015
Financial ratios for ALGOQUANT.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 5604538.939321548
Buffett classification: The Gruesome
Shares outstanding: 281096028
Book value: 5605697.563306259
Debt to equity: 0.6830105538142247
Current ratio: 1.997816682517223
Quick ratio: 1.997816682517223
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALGOQUANT.NS — annual report dated 2025-03-31
Total revenue: 5019639.934533551
Gross profit: -659948.5620762216
Operating income: 5097299.509001636
Net income: 3728594.809445873
Capital expenditures: 424397.9424830488
Operating cash flow: 7058498.94786065
Depreciation & amortization: 542167.407061024
Net tangible assets: 11773988.777180266
Owner earnings: 3846364.2740238477
Return on net tangible assets (%): 32.66831952038778
Capex to operating income (%): 8.32593693451951
Buffett classification: The Great
Shares outstanding: 281096028
Book value: 11801414.542903904
Debt to equity: 0.33751794217493336
Current ratio: 1.1018355061491303
Quick ratio: 1.1018355061491303
Effective tax rate (%): 14.066474113031857
Interest coverage ratio: 6.678966959239005
COGS to revenue (%): 113.14732870650705
SG&A to revenue (%): 14.640877544366296
Free cash flow (dilution-adjusted): 6634101.005377601
Receivables turnover: 25.0032027019158
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 40.66062571163998
FCF margin (%): 132.16288602170573
Revenue growth (%): -67.2775064089999
Rule of 40 score: 64.88537961270583
Financial ratios for ALGOQUANT.NS — quarterly report dated 2025-03-31
Total revenue: 1292623.3341126957
Gross profit: -677764.7884030862
Operating income: 213970.07248071078
Net income: 71861.11760579846
Capital expenditures: 0
Depreciation & amortization: 113841.4776712649
Net tangible assets: 11773988.777180266
Owner earnings: 185702.59527706337
Return on net tangible assets (%): 1.5772275546667966
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 281096028
Book value: 11801426.233341126
Debt to equity: 0.3375176078312501
Current ratio: 16.876457964820286
Quick ratio: 16.876457964820286
Interest coverage ratio: 0.9529834426741643
COGS to revenue (%): 152.43327816516086
Receivables turnover: 6.438653700576486
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.8954255656400802
Rule of 40 score: 0
Financial ratios for ALGOQUANT.NS — quarterly report dated 2025-06-30
Total revenue: 938754.9730868243
Gross profit: -545974.7250175521
Operating income: 963234.261642874
Net income: 519751.9307278259
Capital expenditures: 0
Depreciation & amortization: 133465.9489819799
Owner earnings: 653217.8797098058
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 281096028
Effective tax rate (%): 32.188330127324356
Interest coverage ratio: 4.845941013716372
COGS to revenue (%): 158.15944955500711
Capitalized R&D asset: 0
Revenue growth (%): -27.37598430162795
Rule of 40 score: -27.37598430162795
Financial ratios for ALGOQUANT.NS — quarterly report dated 2025-09-30
Total revenue: 541488.1623449831
Gross profit: -588241.2626832018
Operating income: 1063540.0225479142
Net income: 708838.7824126268
Capital expenditures: 0
Depreciation & amortization: 117576.099210823
Net tangible assets: 12564577.226606539
Owner earnings: 826414.8816234497
Return on net tangible assets (%): 6.577339346312802
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 281096028
Book value: 12593325.817361893
Debt to equity: 0.23754820828126066
Current ratio: 10.539648990375541
Quick ratio: 10.539648990375541
Effective tax rate (%): 29.459216874228648
Interest coverage ratio: 18.32834660967554
COGS to revenue (%): 208.63418696647932
Receivables turnover: 8.146200814111262
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.2982395789241545
Revenue growth (%): -42.31847735895813
Rule of 40 score: -42.31847735895813
Financial ratios for ALGOQUANT.NS — quarterly report dated 2025-12-31
Total revenue: 1230611.562882923
Gross profit: -45805.94853514538
Operating income: 1124495.9340536927
Net income: 654093.7952545395
Capital expenditures: 0
Depreciation & amortization: 120686.19806171328
Owner earnings: 774779.9933162527
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 281096028
Effective tax rate (%): 33.86271992070465
Interest coverage ratio: 8.151324289405684
COGS to revenue (%): 103.7222101527989
Capitalized R&D asset: 0
Revenue growth (%): 127.26472127361082
Rule of 40 score: 127.26472127361082
Financial ratios for BIO.AX — annual report dated 2021-06-30
Capital expenditures: 0
Net tangible assets: 7647368.421052631
Buffett classification: The Gruesome
Shares outstanding: 227998033
Book value: 7647368.421052631
Debt to equity: 0.007963818700226133
Current ratio: 12.847953216374268
Quick ratio: 12.847953216374268
Retained earnings: -8357142.857142856
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CDO.AX — annual report dated 2021-06-30
Capital expenditures: 0
Net tangible assets: 54792359.39849624
Buffett classification: The Gruesome
Shares outstanding: 15759227
Book value: 54792359.39849624
Debt to equity: 0.1266236313778341
Retained earnings: -35658.64661654135
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CDO.AX — annual report dated 2022-06-30
Total revenue: -1286871.7241379311
Net income: -1048415.1724137932
Capital expenditures: 0
Net tangible assets: 24143975.862068966
Owner earnings: -1048415.1724137932
Return on net tangible assets (%): -4.342346837998998
Buffett classification: The Gruesome
Shares outstanding: 15759227
Book value: 24143975.862068966
Debt to equity: 0.2932686143027325
Free cash flow (dilution-adjusted): 2363009.6551724137
Retained earnings: -3284028.9655172415
Receivables turnover: -0.6530064598493017
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CDO.AX — annual report dated 2023-06-30
Total revenue: -914981.4569536424
Net income: -889321.1920529801
Capital expenditures: 0
Net tangible assets: 21311888.741721854
Owner earnings: -889321.1920529801
Return on net tangible assets (%): -4.172887738063187
Buffett classification: The Gruesome
Shares outstanding: 15759227
Book value: 21311888.741721854
Debt to equity: 0.2384471410292648
Free cash flow (dilution-adjusted): -1851733.774834437
Retained earnings: -4042858.940397351
Receivables turnover: -2.6570675795222893
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ITHA — quarterly report dated 2025-07-31
Capital expenditures: 0
Net tangible assets: 10562
Buffett classification: The Gruesome
Shares outstanding: 23000000
Book value: 10562
Debt to equity: 0.9865555765953418
Quick ratio: 0
Retained earnings: -14438
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ITHA — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -37638
Net income: -37638
Capital expenditures: 0
Operating cash flow: 0
Net tangible assets: -12638
Owner earnings: -37638
Buffett classification: The Gruesome
Shares outstanding: 23000000
Book value: -12638
Debt to equity: -0.8957113467320779
Quick ratio: 0
Free cash flow (dilution-adjusted): 0
Retained earnings: -37638
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ITHA — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -314488
Net income: -18406
Capital expenditures: 0
Operating cash flow: -341480
Owner earnings: -18406
Buffett classification: The Gruesome
Shares outstanding: 23000000
Free cash flow (dilution-adjusted): -341480
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ITHA — annual report dated 2025-12-31
Capital expenditures: 0
Net tangible assets: 221475810
Buffett classification: The Gruesome
Shares outstanding: 23000000
Book value: 221475810
Debt to equity: 0
Current ratio: 9.837741617761727
Quick ratio: 9.837741617761727
Retained earnings: -8821039
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OBAI — annual report dated 2023-12-31
Capital expenditures: 0
Operating cash flow: -6996000
Buffett classification: The Gruesome
Shares outstanding: 24462071
Free cash flow (dilution-adjusted): -7085000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OBAI — quarterly report dated 2024-12-31
Capital expenditures: 16000
Net tangible assets: -16513000
Buffett classification: The Gruesome
Shares outstanding: 24462071
Book value: -16513000
Debt to equity: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OBAI — annual report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -16513000
Buffett classification: The Gruesome
Shares outstanding: 24462071
Book value: -16513000
Debt to equity: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OBAI — quarterly report dated 2025-03-31
Total revenue: 2249000
Gross profit: 73000
Operating income: -1785000
Net income: -2162000
Capital expenditures: 0
Operating cash flow: -1416000
Depreciation & amortization: 12000
Owner earnings: -2150000
Buffett classification: The Gruesome
Shares outstanding: 24462071
Interest coverage ratio: -4.73474801061008
COGS to revenue (%): 96.75411293908404
R&D to revenue (%): 24.6776345042241
SG&A to revenue (%): 57.936860827034245
Free cash flow (dilution-adjusted): -1498000
Capitalized R&D asset: 555000
ROCI (R&D-adjusted, %): -254.95495495495499
FCF margin (%): -66.60738105824811
Rule of 40 score: -66.60738105824811
Financial ratios for OBAI — quarterly report dated 2025-06-30
Total revenue: 2275000
Gross profit: 335000
Operating income: -2737000
Net income: -3035000
Capital expenditures: 8000
Operating cash flow: -1579000
Depreciation & amortization: 13000
Owner earnings: -3030000
Buffett classification: The Gruesome
Shares outstanding: 24462071
Interest coverage ratio: -7.417344173441735
COGS to revenue (%): 85.27472527472527
R&D to revenue (%): 29.186813186813186
SG&A to revenue (%): 105.84615384615385
Free cash flow (dilution-adjusted): -2300000
Capitalized R&D asset: 1035850
ROCI (R&D-adjusted, %): -239.3525446090972
Rosenberg metric: 0.4720720720720721
FCF margin (%): -101.0989010989011
Revenue growth (%): 1.1560693641618496
Rule of 40 score: -99.94283173473924
Financial ratios for OBAI — quarterly report dated 2025-09-30
Total revenue: 2736000
Gross profit: 116000
Operating income: -2280000
Net income: -2634000
Capital expenditures: 10000
Operating cash flow: -2115000
Depreciation & amortization: 12000
Net tangible assets: -10400000
Owner earnings: -2632000
Buffett classification: The Gruesome
Shares outstanding: 24462071
Book value: -10400000
Debt to equity: -0.7809615384615385
Current ratio: 0.44335287593091427
Quick ratio: 0.44335287593091427
Interest coverage ratio: -7.169811320754717
COGS to revenue (%): 95.76023391812866
R&D to revenue (%): 23.099415204678362
SG&A to revenue (%): 64.47368421052632
Free cash flow (dilution-adjusted): -2355000
Retained earnings: -136112000
Receivables turnover: 1.5842501447596988
Capitalized R&D asset: 1260030
Rosenberg metric: -0.32981927710843373
FCF margin (%): -86.07456140350878
Revenue growth (%): 20.263736263736266
Rule of 40 score: -65.81082513977252
Financial ratios for OBAI — quarterly report dated 2025-12-31
Total revenue: 2718000
Gross profit: 50000
Operating income: -2452000
Net income: -2718000
Capital expenditures: 16000
Operating cash flow: -1812000
Depreciation & amortization: 16000
Net tangible assets: -11274000
Owner earnings: -2718000
Buffett classification: The Gruesome
Shares outstanding: 24462071
Book value: -11274000
Debt to equity: -0.7075572112825971
Current ratio: 0.2974870657797487
Quick ratio: 0.2974870657797487
Interest coverage ratio: -12.510204081632653
COGS to revenue (%): 98.16041206769684
R&D to revenue (%): 24.834437086092713
SG&A to revenue (%): 79.80132450331125
Free cash flow (dilution-adjusted): -1951000
Retained earnings: -139152000
Receivables turnover: 1.7072864321608041
Capitalized R&D asset: 1317560
Rosenberg metric: -0.10443037974683544
FCF margin (%): -71.78072111846946
Revenue growth (%): -0.6578947368421052
Rule of 40 score: -72.43861585531157
Financial ratios for OBAI — annual report dated 2025-12-31
Total revenue: 9972000
Gross profit: 566000
Operating income: -9252000
Net income: -10549000
Capital expenditures: 34000
Operating cash flow: -6922000
Depreciation & amortization: 53000
Net tangible assets: -11274000
Owner earnings: -10530000
Buffett classification: The Gruesome
Shares outstanding: 24462071
Book value: -11274000
Debt to equity: -0.7075572112825971
Current ratio: 0.2974870657797487
Quick ratio: 0.2974870657797487
Interest coverage ratio: -7.33122028526149
COGS to revenue (%): 94.32410750100281
R&D to revenue (%): 25.330926594464497
SG&A to revenue (%): 73.1247492980345
Free cash flow (dilution-adjusted): -8104000
Retained earnings: -139152000
Receivables turnover: 6.263819095477387
Capitalized R&D asset: 2526000
FCF margin (%): -81.26754913758523
Rule of 40 score: -81.26754913758523
Financial ratios for SOC.AX — annual report dated 2021-06-30
Total revenue: 5906706.015037593
Gross profit: 5906706.015037593
Operating income: 1276629.3233082707
Net income: 952802.2556390977
Capital expenditures: 181682.70676691728
Depreciation & amortization: 165015.03759398495
Net tangible assets: 1499454.887218045
Owner earnings: 936134.5864661654
Return on net tangible assets (%): 62.431660628549224
Capex to operating income (%): 14.231437696895666
Buffett classification: The Great
Shares outstanding: 139355091
Book value: 1504704.511278195
Debt to equity: 0.07100187532136054
Current ratio: 1.9063630877196132
Quick ratio: 1.9063630877196132
Effective tax rate (%): 27.579910711224194
Interest coverage ratio: 227.389446899692
COGS to revenue (%): 0
SG&A to revenue (%): 58.51960795420625
Free cash flow (dilution-adjusted): 973356.3909774435
Retained earnings: 1504679.6992481202
Receivables turnover: 4.477784408645359
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 78.24159771807227
FCF margin (%): 16.47883589431103
Rule of 40 score: 16.47883589431103
Financial ratios for SOC.AX — annual report dated 2022-06-30
Capital expenditures: 0
Net tangible assets: 2782.7586206896553
Buffett classification: The Gruesome
Shares outstanding: 139355091
Book value: 2787.5862068965525
Debt to equity: 0.0623453735774369
Current ratio: 2.6077586206896552
Quick ratio: 2.6077586206896552
Retained earnings: -860
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for WAST.TO — annual report dated 2022-12-31
Total revenue: 14483823529.411764
Gross profit: 5444117647.058824
Operating income: 2520588235.2941175
Net income: 1647058823.5294116
Capital expenditures: 1902205882.352941
Operating cash flow: 3335294117.6470585
Depreciation & amortization: 1498529411.7647057
Net tangible assets: -2427205882.352941
Owner earnings: 1243382352.941176
Return on net tangible assets (%): -51.22690093910934
Capex to operating income (%): 75.46674445740958
Buffett classification: The Gruesome
Shares outstanding: 5732723766
Book value: 5047058823.529415
Debt to equity: 2.1829836829836813
Current ratio: 0.8081474738279472
Quick ratio: 0.7708238507055075
Effective tax rate (%): 23.235092529129542
Interest coverage ratio: 9.06878306878307
COGS to revenue (%): 62.41242765763021
SG&A to revenue (%): 9.58472941415372
Free cash flow (dilution-adjusted): 1371323529.4117646
Retained earnings: 9681617647.058823
Inventory turnover: 74.96341463414633
Receivables turnover: 7.157703488372094
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.709005301597895
FCF margin (%): 9.46796629099401
Rule of 40 score: 9.46796629099401
Financial ratios for WAST.TO — annual report dated 2023-12-31
Total revenue: 15474242424.242424
Gross profit: 5924242424.242424
Operating income: 2896212121.212121
Net income: 1745454545.4545453
Capital expenditures: 2193181818.181818
Operating cash flow: 3575000000
Depreciation & amortization: 1568939393.9393938
Net tangible assets: -2370454545.4545455
Owner earnings: 1121212121.212121
Return on net tangible assets (%): -47.29945669542984
Capex to operating income (%): 75.72586973580957
Buffett classification: The Gruesome
Shares outstanding: 5732723766
Book value: 5224242424.242424
Debt to equity: 2.353393271461717
Current ratio: 0.9001419782300046
Quick ratio: 0.8592049219119734
Effective tax rate (%): 24.66070837471036
Interest coverage ratio: 7.646
COGS to revenue (%): 61.71546068735925
SG&A to revenue (%): 9.154998531283658
Free cash flow (dilution-adjusted): 1311363636.3636363
Retained earnings: 10859090909.090908
Inventory turnover: 72.86705202312139
Receivables turnover: 7.117073170731708
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.368535161030879
FCF margin (%): 8.474493292862038
Revenue growth (%): 6.838103853029229
Rule of 40 score: 15.312597145891267
Financial ratios for WAST.TO — annual report dated 2024-12-31
Total revenue: 15428671328.67133
Gross profit: 6069930069.93007
Operating income: 2901398601.3986015
Net income: 1920279720.2797203
Capital expenditures: 2259440559.4405594
Operating cash flow: 3769230769.230769
Depreciation & amortization: 1585314685.3146853
Net tangible assets: -6555244755.244756
Owner earnings: 1246153846.1538463
Return on net tangible assets (%): -19.01002773629187
Capex to operating income (%): 77.87418655097613
Buffett classification: The Gruesome
Shares outstanding: 5732723766
Book value: 5772027972.027973
Debt to equity: 2.895565786285437
Current ratio: 0.7628635346756152
Quick ratio: 0.729945669542985
Effective tax rate (%): 20.618854829381146
Interest coverage ratio: 6.938127090301004
COGS to revenue (%): 60.658115396818204
SG&A to revenue (%): 10.03036758373748
Free cash flow (dilution-adjusted): 1427272727.2727273
Retained earnings: 11089510489.51049
Inventory turnover: 64.96601941747572
Receivables turnover: 5.983997830214266
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.830353180714715
FCF margin (%): 9.25078185196936
Revenue growth (%): -0.2944964562510759
Rule of 40 score: 8.956285395718284
Financial ratios for WAST.TO — quarterly report dated 2025-03-31
Total revenue: 4208391608.3916087
Gross profit: 1682517482.5174825
Operating income: 718881118.8811189
Net income: 445454545.4545455
Capital expenditures: 581118881.1188811
Operating cash flow: 844755244.7552449
Depreciation & amortization: 458741258.74125874
Net tangible assets: -6219580419.58042
Owner earnings: 323076923.07692313
Return on net tangible assets (%): -5.194513154935913
Capex to operating income (%): 80.83657587548639
Buffett classification: The Gruesome
Shares outstanding: 5732723766
Book value: 6049650349.6503525
Debt to equity: 2.7554039995376245
Current ratio: 0.8331774827005797
Quick ratio: 0.7924069571722461
Effective tax rate (%): 19.16243654822335
Interest coverage ratio: 4.431034482758621
COGS to revenue (%): 60.019940179461614
SG&A to revenue (%): 11.100033233632436
Free cash flow (dilution-adjusted): 227972027.972028
Retained earnings: 11300699300.6993
Inventory turnover: 16.568807339449542
Receivables turnover: 1.6772575250836121
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.626536191522522
FCF margin (%): 5.417082087072117
Rule of 40 score: 5.417082087072117
Financial ratios for WAST.TO — quarterly report dated 2025-06-30
Total revenue: 4693430656.934306
Gross profit: 1891240875.9124086
Operating income: 866423357.6642336
Net income: 530656934.3065693
Capital expenditures: 534306569.3430657
Operating cash flow: 1127737226.2773721
Depreciation & amortization: 516788321.16788316
Net tangible assets: -6313138686.131387
Owner earnings: 513138686.1313868
Return on net tangible assets (%): -8.128107295641113
Capex to operating income (%): 61.668070766638586
Buffett classification: The Good
Shares outstanding: 5732723766
Book value: 6716788321.167885
Debt to equity: 2.6103021082373385
Current ratio: 0.8569463548830812
Quick ratio: 0.8184319119669877
Effective tax rate (%): 21.659482758620694
Interest coverage ratio: 5.116379310344828
COGS to revenue (%): 59.7045101088647
SG&A to revenue (%): 10.451010886469673
Free cash flow (dilution-adjusted): 563503649.6350365
Retained earnings: 12082481751.824816
Inventory turnover: 17.138392857142858
Receivables turnover: 1.6357161027728313
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.97449005162131
FCF margin (%): 12.006220839813375
Revenue growth (%): 11.525520761317004
Rule of 40 score: 23.531741601130378
Financial ratios for WAST.TO — quarterly report dated 2025-09-30
Total revenue: 4635251798.5611515
Gross profit: 1877697841.7266188
Operating income: 874820143.8848921
Net income: 433812949.6402878
Capital expenditures: 558273381.2949641
Operating cash flow: 1145323741.0071943
Depreciation & amortization: 524460431.6546763
Net tangible assets: -5933812949.640288
Owner earnings: 400000000
Return on net tangible assets (%): -6.741028128031037
Capex to operating income (%): 63.81578947368421
Buffett classification: The Good
Shares outstanding: 5732723766
Book value: 6848920863.309353
Debt to equity: 2.4539915966386556
Current ratio: 0.8434721980128987
Quick ratio: 0.8046017082098658
Effective tax rate (%): 22.193548387096776
Interest coverage ratio: 5.404444444444445
COGS to revenue (%): 59.49092037870557
SG&A to revenue (%): 10.041905944435822
Free cash flow (dilution-adjusted): 556115107.9136691
Retained earnings: 12102877697.841728
Inventory turnover: 17.18834080717489
Receivables turnover: 1.603933283544934
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.049835720197637
FCF margin (%): 11.997516684774173
Revenue growth (%): -1.23958065274062
Rule of 40 score: 10.757936032033552
Financial ratios for 3200.HK — annual report dated 2022-12-31
Total revenue: 400308899.9353449
Gross profit: 149416609.8807471
Operating income: 82073707.16810344
Net income: 62454974.29310345
Capital expenditures: 20655536.136494253
Operating cash flow: 94159876.65804598
Depreciation & amortization: 8766099.712643677
Net tangible assets: 752749532.1178161
Owner earnings: 50565537.869252875
Return on net tangible assets (%): 6.717445273860183
Capex to operating income (%): 25.16705635604782
Buffett classification: The Good
Shares outstanding: 58019500
Book value: 823378053.7456896
Debt to equity: 0.025414679552483516
Current ratio: 4.767053559704714
Quick ratio: 4.071919998229105
Effective tax rate (%): 10.616202391307509
Interest coverage ratio: 38.65473941159372
COGS to revenue (%): 62.67467200832159
R&D to revenue (%): 8.24330549874723
SG&A to revenue (%): 3.926746347348431
Free cash flow (dilution-adjusted): 73495369.57183908
Retained earnings: 156800442.40373564
Inventory turnover: 1.931821315461925
Receivables turnover: 1.6278706354948316
Capitalized R&D asset: 32998685.560344826
ROCI (R&D-adjusted, %): 11.911391171993833
FCF margin (%): 18.359664145291184
Rule of 40 score: 18.359664145291184
Financial ratios for 3200.HK — annual report dated 2023-12-31
Total revenue: 229860911.86216593
Gross profit: 74907781.40506329
Operating income: 22346790.56962025
Net income: 19081234.90857946
Capital expenditures: 34015711.659634314
Operating cash flow: 58618048.86357243
Depreciation & amortization: 8326110.662447257
Net tangible assets: 570575370.4360056
Owner earnings: -6608366.088607594
Return on net tangible assets (%): -1.1581933660329233
Capex to operating income (%): 152.21743611754965
Buffett classification: The Gruesome
Shares outstanding: 58019500
Book value: 659429518.6891701
Debt to equity: 0.0333261472068491
Current ratio: 3.845518437437085
Quick ratio: 3.0512271092309313
Effective tax rate (%): 1.2792173926069599
Interest coverage ratio: 29.398800021193463
COGS to revenue (%): 67.41169222804568
R&D to revenue (%): 11.843745441315793
SG&A to revenue (%): 6.192614991214933
Free cash flow (dilution-adjusted): 24522075.9859353
Retained earnings: 201513.85654008438
Inventory turnover: 1.1333169902532116
Receivables turnover: 1.0947531220317739
Capitalized R&D asset: 49333260.59547323
ROCI (R&D-adjusted, %): 4.107344079641185
Rosenberg metric: -2.257933224019764
FCF margin (%): 10.66822357367126
Revenue growth (%): -42.57911530338409
Rule of 40 score: -31.910891729712834
Financial ratios for 3200.HK — quarterly report dated 2024-09-30
Total revenue: 111158595.94151212
Gross profit: 28262782.472182598
Operating income: 9927917.029957203
Net income: 8532080.590584878
Capital expenditures: 7189167.390870186
Net tangible assets: 625306163.272468
Owner earnings: 1342913.1997146923
Return on net tangible assets (%): 0.21476090891007862
Capex to operating income (%): 72.41365302688449
Buffett classification: The Good
Shares outstanding: 58019500
Book value: 714129377.3737518
Debt to equity: 0.021414015971795628
Current ratio: 2.936595537447042
Quick ratio: 2.3254302980708745
Effective tax rate (%): 1.0077473652124314
Interest coverage ratio: 55.69616265901314
COGS to revenue (%): 74.57436176411088
R&D to revenue (%): 9.371106069932146
SG&A to revenue (%): 21.98721866528559
Free cash flow (dilution-adjusted): -3878132.5135520687
Retained earnings: 29167152.306704707
Inventory turnover: 0.5628568468177322
Receivables turnover: 0.3251059283461207
Capitalized R&D asset: 10416789.93152639
ROCI (R&D-adjusted, %): 2.2922408783880766
FCF margin (%): -3.488828264430949
Rule of 40 score: -3.488828264430949
Financial ratios for 3200.HK — quarterly report dated 2024-12-31
Total revenue: 136918736.869863
Gross profit: 38871225.60821918
Operating income: 17208978.1630137
Net income: 13445325.319178082
Capital expenditures: 5280872.684931507
Net tangible assets: 629757232.9054794
Owner earnings: 8164452.634246575
Return on net tangible assets (%): 1.2964444404359832
Capex to operating income (%): 30.68673011789505
Buffett classification: The Good
Shares outstanding: 58019500
Book value: 703612981.8958905
Debt to equity: 0.050812146756525366
Current ratio: 2.9878189643869457
Quick ratio: 2.48800218973098
Effective tax rate (%): 17.742693857170856
Interest coverage ratio: 54.34294915694691
COGS to revenue (%): 71.61000276743347
R&D to revenue (%): 9.203199744000457
SG&A to revenue (%): -1.2767218898557284
Free cash flow (dilution-adjusted): 29723984.06849315
Retained earnings: 37419204.76712329
Inventory turnover: 0.7968814937589389
Receivables turnover: 0.40467899445674255
Capitalized R&D asset: 19580154.095218573
ROCI (R&D-adjusted, %): 2.9210168185185537
Rosenberg metric: 1.0183984899157992
FCF margin (%): 21.709215807873594
Revenue growth (%): 23.174223019068172
Rule of 40 score: 44.88343882694177
Financial ratios for 3200.HK — annual report dated 2024-12-31
Total revenue: 457957725.72876716
Gross profit: 128732888.94794522
Operating income: 52069908.19726027
Net income: 41257513.55890411
Capital expenditures: 30680361.605479453
Operating cash flow: 21230981.92328767
Depreciation & amortization: 7376087.254794521
Net tangible assets: 629757232.9054794
Owner earnings: 17953239.20821918
Return on net tangible assets (%): 2.85081905695457
Capex to operating income (%): 58.921482037669016
Buffett classification: The Good
Shares outstanding: 58019500
Book value: 703612981.8958905
Debt to equity: 0.050812146756525366
Current ratio: 2.9878189643869457
Quick ratio: 2.48800218973098
Effective tax rate (%): 9.10275081728428
Interest coverage ratio: 37.78230247634464
COGS to revenue (%): 71.88978769970804
R&D to revenue (%): 7.981495913153813
SG&A to revenue (%): 5.714567166024164
Free cash flow (dilution-adjusted): -9469139.59178082
Retained earnings: 37419204.76712329
Inventory turnover: 2.675776022670722
Receivables turnover: 1.3535464625835736
Capitalized R&D asset: 65681618.04885577
ROCI (R&D-adjusted, %): 7.010698045652622
Rosenberg metric: 1.9771094709279886
FCF margin (%): -2.067688579052179
Revenue growth (%): 99.23253676265648
Rule of 40 score: 97.1648481836043
Financial ratios for 3200.HK — quarterly report dated 2025-03-31
Total revenue: 132210560.42424242
Gross profit: 39165481.166666664
Operating income: 22013260.330578513
Net income: 16084502.097796144
Capital expenditures: 5777971.398071625
Net tangible assets: 652938485.0757575
Owner earnings: 10306530.699724518
Return on net tangible assets (%): 1.5784841811749994
Capex to operating income (%): 26.24768576440934
Buffett classification: The Good
Shares outstanding: 58019500
Book value: 728211799.8911846
Debt to equity: 0.24566064438068527
Current ratio: 2.1940947307238274
Quick ratio: 1.7803927567404527
Effective tax rate (%): 10.908611552148317
Interest coverage ratio: 32.48462607644804
COGS to revenue (%): 70.3764351039804
R&D to revenue (%): 6.78226576482373
SG&A to revenue (%): 9.769624898158066
Free cash flow (dilution-adjusted): -51975890.862258956
Retained earnings: 53709873.282369144
Inventory turnover: 0.526445187974558
Receivables turnover: 0.3374303669362205
Capitalized R&D asset: 20847018.498072945
ROCI (R&D-adjusted, %): 2.5953342517588434
Rosenberg metric: 0.023351938782032455
FCF margin (%): -39.312964634199176
Revenue growth (%): -3.438664826491612
Rule of 40 score: -42.751629460690786
Financial ratios for 3200.HK — quarterly report dated 2025-06-30
Total revenue: 198324196.0767085
Gross profit: 60938324.32635984
Operating income: 31072273.9972106
Net income: 20432102.86192469
Capital expenditures: 2990202.355648536
Net tangible assets: 677636214.6331939
Owner earnings: 17441900.506276153
Return on net tangible assets (%): 2.5739327576696143
Capex to operating income (%): 9.623377921799255
Buffett classification: The Great
Shares outstanding: 58019500
Book value: 753325646.6345886
Debt to equity: 0.14585459732778738
Current ratio: 2.163296654389285
Quick ratio: 1.7042564976792138
Effective tax rate (%): 10.820042745449953
Interest coverage ratio: 52.61357521568764
COGS to revenue (%): 69.27337887567188
R&D to revenue (%): 6.596888496473791
SG&A to revenue (%): 0.5712494996054848
Free cash flow (dilution-adjusted): -33086728.419804744
Retained earnings: 51385196.31101813
Inventory turnover: 0.7161093590749815
Receivables turnover: 0.44017030545679053
Capitalized R&D asset: 23249328.630950592
ROCI (R&D-adjusted, %): 4.03387895018369
Rosenberg metric: 2.428142632845628
FCF margin (%): -16.683152673417293
Revenue growth (%): 50.006319797993484
Rule of 40 score: 33.32316712457619
Financial ratios for CTX.TO — annual report dated 2022-12-31
Total revenue: 17297794.11764706
Gross profit: 9692647.05882353
Operating income: 388970.5882352941
Net income: 633823.5294117647
Capital expenditures: 168382.35294117645
Operating cash flow: -750000
Depreciation & amortization: 1081617.6470588234
Net tangible assets: 13404411.764705881
Owner earnings: 1547058.8235294116
Return on net tangible assets (%): 11.541415249588589
Capex to operating income (%): 43.289224952741016
Buffett classification: The Good
Shares outstanding: 18613938
Book value: 15511764.705882352
Debt to equity: 0.07645999241562382
Current ratio: 3.3871553574376754
Quick ratio: 2.455010731385174
Effective tax rate (%): -113.36633663366335
Interest coverage ratio: 3.348101265822785
COGS to revenue (%): 43.96599362380446
R&D to revenue (%): 2.588735387885228
SG&A to revenue (%): 44.94367693942614
Free cash flow (dilution-adjusted): -1080882.3529411764
Retained earnings: -29862499.999999996
Inventory turnover: 1.8319164009918525
Receivables turnover: 3.7706363199230646
Capitalized R&D asset: 447794.1176470588
ROCI (R&D-adjusted, %): 4.058864386178156
FCF margin (%): -6.248671625929862
Rule of 40 score: -6.248671625929862
Financial ratios for CTX.TO — annual report dated 2023-12-31
Total revenue: 13274242.424242424
Gross profit: 7851515.151515151
Operating income: -1481818.1818181816
Net income: -1504545.4545454546
Capital expenditures: 100757.57575757576
Operating cash flow: 1572727.2727272727
Depreciation & amortization: 1140909.0909090908
Net tangible assets: 12749242.424242424
Owner earnings: -464393.9393939395
Return on net tangible assets (%): -3.642521837304654
Buffett classification: The Gruesome
Shares outstanding: 18613938
Book value: 14259090.90909091
Debt to equity: 0.06662416321326108
Current ratio: 3.8007812499999996
Quick ratio: 2.541529605263158
Interest coverage ratio: -23.01176470588235
COGS to revenue (%): 40.85150097020888
R&D to revenue (%): 3.9892706312064825
SG&A to revenue (%): 57.72742837575618
Free cash flow (dilution-adjusted): 1409848.4848484846
Retained earnings: -32271969.696969695
Inventory turnover: 1.1686530612244899
Receivables turnover: 6.314234234234235
Capitalized R&D asset: 829567.5133689839
ROCI (R&D-adjusted, %): -8.099414534570876
Rosenberg metric: -4.111558939145147
FCF margin (%): 10.620933683369477
Revenue growth (%): -23.260490129778123
Rule of 40 score: -12.639556446408646
Financial ratios for CTX.TO — annual report dated 2024-12-31
Total revenue: 13692307.692307692
Gross profit: 6286713.286713287
Operating income: -2248251.7482517483
Net income: -1923076.9230769232
Capital expenditures: 774125.8741258741
Operating cash flow: 1905594.4055944057
Depreciation & amortization: 955244.7552447553
Net tangible assets: 9855244.755244756
Owner earnings: -1741958.041958042
Return on net tangible assets (%): -17.675441708649682
Buffett classification: The Gruesome
Shares outstanding: 18613938
Book value: 11069230.76923077
Debt to equity: 0.052688104112704526
Current ratio: 2.774977334542158
Quick ratio: 2.040435176790571
Interest coverage ratio: -49.46153846153846
COGS to revenue (%): 54.08580183861083
R&D to revenue (%): 3.2992849846782435
SG&A to revenue (%): 55.21450459652707
Free cash flow (dilution-adjusted): 950349.6503496504
Retained earnings: -31712587.412587415
Inventory turnover: 2.614169340903481
Receivables turnover: 11.41025641025641
Capitalized R&D asset: 954315.7651172357
ROCI (R&D-adjusted, %): -18.440140117648333
Rosenberg metric: -2.9549906459777695
FCF margin (%): 6.940755873340143
Revenue growth (%): 3.14944728824423
Rule of 40 score: 10.090203161584373
Financial ratios for CTX.TO — quarterly report dated 2025-03-31
Total revenue: 2473426.5734265735
Gross profit: 1097902.097902098
Operating income: -742657.3426573427
Net income: -651748.2517482517
Capital expenditures: 46153.846153846156
Operating cash flow: -358741.25874125876
Depreciation & amortization: 246853.14685314687
Net tangible assets: 9286713.286713287
Owner earnings: -451048.951048951
Return on net tangible assets (%): -4.856927710843372
Buffett classification: The Gruesome
Shares outstanding: 18613938
Book value: 10396503.496503497
Debt to equity: 0.048294881280688776
Current ratio: 2.3647703072710677
Quick ratio: 1.589443261332522
Interest coverage ratio: -88.5
COGS to revenue (%): 55.612100650268594
R&D to revenue (%): 3.7037037037037033
SG&A to revenue (%): 65.73367260390161
Free cash flow (dilution-adjusted): -425874.12587412586
Retained earnings: -32364335.664335664
Inventory turnover: 0.3859132823229351
Receivables turnover: 2.257179323548181
Capitalized R&D asset: 91608.39160839161
ROCI (R&D-adjusted, %): -6.364962232525741
FCF margin (%): -17.217981340118744
Rule of 40 score: -17.217981340118744
Financial ratios for CTX.TO — quarterly report dated 2025-06-30
Total revenue: 4549635.03649635
Gross profit: 2791970.8029197077
Operating income: 425547.4452554744
Net income: 582481.7518248175
Capital expenditures: 124087.5912408759
Operating cash flow: -2189.78102189781
Depreciation & amortization: 257664.23357664232
Net tangible assets: 10345985.401459854
Owner earnings: 716058.394160584
Return on net tangible assets (%): 6.9211231832933535
Capex to operating income (%): 29.15951972555746
Buffett classification: The Good
Shares outstanding: 18613938
Book value: 11395620.437956203
Debt to equity: 0.038560081988214194
Current ratio: 2.59660961158657
Quick ratio: 1.7848913759052007
Interest coverage ratio: 48.58333333333333
COGS to revenue (%): 38.633081982993744
R&D to revenue (%): 2.2621530563131724
SG&A to revenue (%): 44.08791914006097
Free cash flow (dilution-adjusted): -146715.32846715327
Retained earnings: -33199270.072992697
Inventory turnover: 0.4882400648824006
Receivables turnover: 2.749448610498456
Capitalized R&D asset: 164297.33040681947
ROCI (R&D-adjusted, %): 3.961097857420471
Rosenberg metric: 18.49250571126093
FCF margin (%): -3.2247713781485645
Revenue growth (%): 83.94057399462199
Rule of 40 score: 80.71580261647343
Financial ratios for CTX.TO — quarterly report dated 2025-09-30
Total revenue: 3879856.115107914
Gross profit: 2053956.8345323743
Operating income: -116546.76258992807
Net income: 541726.618705036
Capital expenditures: 33093.525179856115
Operating cash flow: 843884.892086331
Depreciation & amortization: 276258.9928057554
Net tangible assets: 10521582.73381295
Owner earnings: 784892.0863309352
Return on net tangible assets (%): 7.45982905982906
Buffett classification: The Gruesome
Shares outstanding: 18613938
Book value: 11694964.02877698
Debt to equity: 0.029773622047244094
Current ratio: 3.121460652216364
Quick ratio: 2.074204256981058
Interest coverage ratio: -16.2
COGS to revenue (%): 47.06100500648989
R&D to revenue (%): 2.558872612646023
SG&A to revenue (%): 46.26367513443353
Free cash flow (dilution-adjusted): 805755.3956834533
Retained earnings: -32179856.115107916
Inventory turnover: 0.4732425881036733
Receivables turnover: 2.8220826792255367
Capitalized R&D asset: 198467.54914989963
ROCI (R&D-adjusted, %): -0.9640154541002985
Rosenberg metric: -7.170774019082602
FCF margin (%): 20.767661783793805
Revenue growth (%): -14.721596699858125
Rule of 40 score: 6.04606508393568
Financial ratios for CTX.TO — annual report dated 2025-12-31
Total revenue: 15414598.540145984
Gross profit: 8108759.124087591
Operating income: -745985.401459854
Net income: -67153.28467153285
Capital expenditures: 243065.69343065692
Operating cash flow: 783211.6788321168
Depreciation & amortization: 1095620.4379562044
Net tangible assets: 10302919.708029196
Owner earnings: 785401.4598540147
Buffett classification: The Gruesome
Shares outstanding: 18613938
Book value: 11369343.065693429
Debt to equity: 0.021443246019517206
Current ratio: 3.330790421699512
Quick ratio: 2.330154693791057
Interest coverage ratio: -24.333333333333336
COGS to revenue (%): 47.3955867032863
R&D to revenue (%): 2.7180604223884837
SG&A to revenue (%): 51.24064778861634
Free cash flow (dilution-adjusted): 488321.1678832117
Retained earnings: -33168613.138686128
Inventory turnover: 2.119652689538331
Receivables turnover: 9.99432087079981
Capitalized R&D asset: 896399.4308611096
ROCI (R&D-adjusted, %): -6.458710682687367
Rosenberg metric: 4.033321280875006
FCF margin (%): 3.167913628184488
Revenue growth (%): 12.578528663987527
Rule of 40 score: 15.746442292172015
Financial ratios for CTX.TO — quarterly report dated 2025-12-31
Total revenue: 4346715.328467153
Gross profit: 1957664.2335766421
Operating income: -278102.18978102185
Net income: -518978.10218978097
Capital expenditures: 37226.27737226277
Operating cash flow: 303649.63503649633
Depreciation & amortization: 300000
Net tangible assets: 10302919.708029196
Owner earnings: -256204.37956204373
Return on net tangible assets (%): -2.486716259298618
Buffett classification: The Gruesome
Shares outstanding: 18613938
Book value: 11369343.065693429
Debt to equity: 0.021443246019517206
Current ratio: 3.330790421699512
Quick ratio: 2.330154693791057
Interest coverage ratio: -47.62499999999999
COGS to revenue (%): 54.962216624685134
R&D to revenue (%): 2.753988245172124
SG&A to revenue (%): 54.626364399664155
Free cash flow (dilution-adjusted): 262043.79562043792
Retained earnings: -33168613.138686128
Inventory turnover: 0.693138500635324
Receivables turnover: 2.818267865593942
Capitalized R&D asset: 220189.5184582261
ROCI (R&D-adjusted, %): -2.287804556144008
Rosenberg metric: -0.9699037342642587
FCF margin (%): 6.0285474391267835
Revenue growth (%): 12.032900177440057
Rule of 40 score: 18.06144761656684
Financial ratios for EFTY — annual report dated 2023-12-31
Total revenue: 8177.0806658130605
Gross profit: 6541.613316261204
Operating income: 4536.107554417414
Net income: 4186.427656850192
Capital expenditures: 0
Operating cash flow: 8187.580025608195
Depreciation & amortization: 0
Net tangible assets: 4051.472471190781
Owner earnings: 4186.427656850192
Return on net tangible assets (%): 103.3310157385753
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 15110000
Book value: 4051.47247119078
Debt to equity: 0
Current ratio: 1.8148014626358344
Quick ratio: 1.8148014626358344
Effective tax rate (%): 7.708809664944817
COGS to revenue (%): 20.00062634076069
SG&A to revenue (%): 24.525938336752112
Free cash flow (dilution-adjusted): 8187.580025608195
Retained earnings: 3741.6133162612036
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 111.96194930788195
FCF margin (%): 100.12839985594162
Rule of 40 score: 100.12839985594162
Financial ratios for EFTY — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 114457.98969072165
Buffett classification: The Gruesome
Shares outstanding: 15110000
Book value: 114457.98969072165
Debt to equity: 0.060142266216614844
Current ratio: 1.5037706223843461
Quick ratio: 1.5037706223843461
Retained earnings: 113623.84020618557
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EFTY — annual report dated 2024-12-31
Total revenue: 325503.73711340205
Gross profit: 256575.90206185568
Operating income: 128943.29896907217
Net income: 109858.11855670104
Capital expenditures: 9692.654639175258
Operating cash flow: 209132.47422680413
Depreciation & amortization: 9681.829896907217
Net tangible assets: 114457.98969072165
Owner earnings: 109847.293814433
Return on net tangible assets (%): 95.97171338694025
Capex to operating income (%): 7.51698980611633
Buffett classification: The Great
Shares outstanding: 15110000
Book value: 114457.98969072165
Debt to equity: 0.060142266216614844
Current ratio: 1.5037706223843461
Quick ratio: 1.5037706223843461
Effective tax rate (%): 14.486375983533218
Interest coverage ratio: 265.4111405835544
COGS to revenue (%): 21.17574306912878
SG&A to revenue (%): 39.21079500488735
Free cash flow (dilution-adjusted): 199439.81958762888
Retained earnings: 113623.84020618557
Receivables turnover: 7.976747858106038
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 112.07801328672188
FCF margin (%): 61.27113051182763
Revenue growth (%): 3880.6839435286
Rule of 40 score: 3941.955074040428
Financial ratios for EFTY — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 191367.1337579618
Buffett classification: The Gruesome
Shares outstanding: 15110000
Book value: 191367.1337579618
Debt to equity: 0.18288653150778308
Current ratio: 1.239264048025519
Quick ratio: 1.239264048025519
Retained earnings: 192324.96815286626
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EMPG — annual report dated 2021-12-31
Total revenue: 1395340.9520383691
Gross profit: 356485.3717026379
Operating income: 247727.88009592326
Net income: 194688.73621103118
Capital expenditures: 3183.73860911271
Operating cash flow: 149794.34052757794
Depreciation & amortization: 19557.12470023981
Net tangible assets: 189216.12709832133
Owner earnings: 211062.12230215827
Return on net tangible assets (%): 111.545524971286
Capex to operating income (%): 1.2851757371354113
Buffett classification: The Great
Shares outstanding: 8240000
Book value: 189216.12709832145
Debt to equity: 0.8283993187849018
Current ratio: 1.5086896513021908
Quick ratio: 1.0494392412373057
Effective tax rate (%): 23.987266632667552
Interest coverage ratio: 36.71605358635632
COGS to revenue (%): 74.4517373204112
SG&A to revenue (%): 7.794330944550677
Free cash flow (dilution-adjusted): 146610.60431654676
Retained earnings: 166248.74580335733
Inventory turnover: 6.853357829553589
Receivables turnover: 6.963801604008763
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 76.75220003538537
FCF margin (%): 10.507152685683897
Rule of 40 score: 10.507152685683897
Financial ratios for EMPG — annual report dated 2022-12-31
Total revenue: 2448321.040723982
Gross profit: 676521.9457013574
Operating income: 372008.82352941175
Net income: 264625.5656108597
Capital expenditures: 48104.97737556561
Operating cash flow: 467520.13574660633
Depreciation & amortization: 32895.47511312217
Net tangible assets: 319993.4389140272
Owner earnings: 249416.0633484163
Return on net tangible assets (%): 77.94411791531358
Capex to operating income (%): 12.931138815249724
Buffett classification: The Great
Shares outstanding: 8240000
Book value: 319993.4389140272
Debt to equity: 0.581126168452266
Current ratio: 1.5965764094662176
Quick ratio: 1.4556704559703844
Effective tax rate (%): 27.80829197509186
Interest coverage ratio: 57.17640308783643
COGS to revenue (%): 72.3679233871508
SG&A to revenue (%): 12.43763040495292
Free cash flow (dilution-adjusted): 419415.1583710407
Retained earnings: 301407.9185520362
Inventory turnover: 31.392839819933215
Receivables turnover: 8.308658477971447
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 78.82948489549673
FCF margin (%): 17.130725562323207
Revenue growth (%): 75.46399947248575
Rule of 40 score: 92.59472503480896
Financial ratios for EMPG — annual report dated 2023-12-31
Total revenue: 801892.1908893709
Gross profit: 321878.95878524944
Operating income: -50827.33188720173
Net income: -68978.30802603037
Capital expenditures: 60416.70281995661
Operating cash flow: -197902.16919739696
Depreciation & amortization: 56004.33839479392
Net tangible assets: 160783.94793926246
Owner earnings: -73390.67245119307
Return on net tangible assets (%): -45.645522075945685
Buffett classification: The Gruesome
Shares outstanding: 8240000
Book value: 160783.9479392625
Debt to equity: 2.0744967040557785
Current ratio: 1.4531828006740741
Quick ratio: 1.4273606773402645
Interest coverage ratio: -3.4884247197367837
COGS to revenue (%): 59.86007066258413
SG&A to revenue (%): 46.47835393671638
Free cash flow (dilution-adjusted): -266395.44468546635
Retained earnings: 102135.1409978308
Inventory turnover: 48.591589811155025
Receivables turnover: 2.204377242109682
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -11.600420818119934
FCF margin (%): -33.220855335928604
Revenue growth (%): -67.24726138642966
Rule of 40 score: -100.46811672235826
Financial ratios for HREE.L — annual report dated 2023-06-30
Capital expenditures: 0
Net tangible assets: -469072.15189873416
Buffett classification: The Gruesome
Shares outstanding: 684060108
Book value: 362930.3797468357
Debt to equity: 14.195281028198725
Current ratio: 0.37306507677530115
Quick ratio: 0.37306507677530115
Retained earnings: -1677932.911392405
Capitalized R&D asset: 0
Rule of 40 score: 0